procaterol has been researched along with Coronary Disease in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noguchi, K | 1 |
| Ojiri, Y | 1 |
| Chibana, T | 1 |
| Moromizato, H | 1 |
| Sakanashi, M | 1 |
1 other study available for procaterol and Coronary Disease
| Article | Year |
|---|---|
Cardiac effects of beta-2 adrenoceptor stimulation with intracoronary procaterol in the absence and presence of regional myocardial ischemia in dogs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Coronary Disea | 1991 |